Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SUKESHI P ARORA

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1386805604
CMS profile
62393
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$154,353.30

  • Reported across 127 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$38,935.97

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $29,758.77 19
Tempus AI, Inc $5,325.22 2
AstraZeneca UK Limited $3,690.00 1
PFIZER INC. $123.40 1
Gilead Sciences, Inc. $21.56 1
Regeneron Healthcare Solutions, Inc. $17.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,965.39 13
PY2019 $23,710.02 25
PY2020 $3,387.94 4
PY2021 $7,997.69 7
PY2022 $27,292.60 16
PY2023 $48,063.69 37
PY2024 $38,935.97 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $195.45 02/20/2024 Travel and Lodging Undisputed 01/23/2026 1104672751 CMS
AstraZeneca Pharmaceuticals LP $150.77 02/20/2024 Travel and Lodging Undisputed 01/23/2026 1105671317 CMS
AstraZeneca Pharmaceuticals LP $34.42 02/20/2024 Food and Beverage Undisputed 01/23/2026 1105709156 CMS
AstraZeneca Pharmaceuticals LP $5,500.00 02/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104353058 CMS
AstraZeneca Pharmaceuticals LP $90.36 03/26/2024 Food and Beverage Undisputed 01/23/2026 1105805790 CMS
AstraZeneca Pharmaceuticals LP $125.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 1104607178 CMS
AstraZeneca Pharmaceuticals LP $650.11 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1105841361 CMS
AstraZeneca Pharmaceuticals LP $4,100.00 05/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104334504 CMS
AstraZeneca Pharmaceuticals LP $1,246.76 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1104371831 CMS
AstraZeneca Pharmaceuticals LP $100.05 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1105427109 CMS
AstraZeneca Pharmaceuticals LP $38.94 06/11/2024 Food and Beverage Undisputed 01/23/2026 1105462807 CMS
AstraZeneca Pharmaceuticals LP $498.44 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1105720096 CMS
AstraZeneca Pharmaceuticals LP $189.25 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1105727167 CMS
AstraZeneca Pharmaceuticals LP $99.22 06/11/2024 Food and Beverage Undisputed 01/23/2026 1105881058 CMS
AstraZeneca Pharmaceuticals LP $5,500.00 06/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104761626 CMS
AstraZeneca Pharmaceuticals LP $5,500.00 06/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105410484 CMS
AstraZeneca Pharmaceuticals LP $1,350.00 08/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104763336 CMS
AstraZeneca Pharmaceuticals LP $2,750.00 10/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104209587 CMS
AstraZeneca Pharmaceuticals LP $1,640.00 12/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105583692 CMS
AstraZeneca UK Limited $3,690.00 12/18/2024 Consulting Fee Undisputed 01/23/2026 1093892714 CMS
Gilead Sciences, Inc. $21.56 05/07/2024 Food and Beverage Undisputed 01/23/2026 1133832722 CMS
PFIZER INC. $123.40 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131918449 CMS
Regeneron Healthcare Solutions, Inc. $17.02 11/15/2024 Education Undisputed 01/23/2026 1114133852 CMS
Tempus AI, Inc $75.22 03/05/2024 Food and Beverage Undisputed 01/23/2026 1150171703 CMS
Tempus AI, Inc $5,250.00 04/22/2024 Consulting Fee Undisputed 01/23/2026 1150171705 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.